Researcher develops app to reach Black community with COVID-19 information

In Ohio as of Oct. 28, 2020, there were 205,347 cases of COVID-19 which include 18,606 hospitalizations and 5,256 deaths, as reported by the Ohio Department of Health. Black residents in Ohio accounted for 14% of the population but 16.7% of COVID-19 cases and 17.1% of COVID-19 deaths. Black residents account for 25.7% of the COVID-19 hospitalizations.

Lynch is working with public health researchers, Tilicia Mayo-Gamble, PhD, at Georgia Southern University, and Kelly Harris, PhD, at Washington University in St. Louis, to conduct a yearlong study in which the smartphone app is designed based on conversations with focus groups in Cincinnati, St. Louis and Statesboro, Georgia.

“We will have a stakeholder group in each of those communities,” says Lynch. “We will ask the stakeholders how people perceive they are receiving their health care information and information on COVID-19. We will ask questions about the use of smartphones.”

“This is an implementation science-based project,” says Lynch. “We are going to ask questions as to how satisfied they are with current available health information and what information you feel is missing. What more information is needed and where are the gaps?”

“Based on the feedback we will build our app,” says Lynch. “The stakeholder conversations will conclude at the end of three months, and we hope to get a pilot version of our app available for community members to test. We know many people have access to smartphones and we think this will work well for our study.”

Lynch is seeing heart patients who have recovered from COVID-19 now coming in for treatment with conditions that may be related to the pandemic.

“We are learning more and more about COVID every day, and we know COVID can affect the heart itself,” says Lynch. “Now we are seeing patients that are COVID-positive. They have survived and are a month or more out and they have manifestations of heart palpitations, problems regulating blood pressure and other concerns. It’s not clear if this is a result of COVID or if those symptoms were present before COVID and now we are just paying more attention to signals from our body.”

Lynch participated in the 2019 PRIDE-Functional and Translational Genomics of Blood Disorder program (PRIDE-FTG) at Augusta University in Augusta, Georgia. PRIDE (Programs to Increase Diversity among Individuals Engaged in Health-Related Research) is a research career-advancing training opportunity funded by the National Heart, Lung, and Blood Institute (NHLBI) of the NIH. There Lynch met co-investigators Mayo-Gamble and Harris. The goal of PRIDE is to train junior-level faculty to do research related to blood disorders such as hemoglobinopathies and white blood cell and platelet diseases.

Featured image at top: Donald Lynch, MD, in a UC College of Medicine laboratory. Photo/Colleen Kelley/UC Creative +Brand